Skip to main content

Health condition · Clinically reviewed

Pancreatic cancer, early diagnosis is difficult — modern staging and multimodal care.

Pancreatic ductal adenocarcinoma is often diagnosed late. Modern imaging (MRCP, EUS), FOLFIRINOX chemotherapy, and specialist HPB surgery have improved outcomes for resectable disease.

Jump to treatment See red-flag symptoms
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced, not summarised

    Every claim is checked against NICE, ESMO or a peer-reviewed source you can see at the end.

  • 03

    Updated for 2026

    Reflects current UK guidance on pancreas-protocol CT, EUS-guided biopsy and modern systemic therapy.

Key facts

Pancreatic cancer at a glance.

The essentials, in plain English — what it is, how common it is, how it’s diagnosed in the UK today, and how treatment is chosen.

  • What it is

    Pancreatic ductal adenocarcinoma (PDAC) is the most common type — a cancer arising from the pancreatic duct cells.

  • How common

    Around 10,500 new cases each year in the UK.

  • Who is at risk

    Family history, BRCA mutations and hereditary pancreatitis all raise the risk.

  • Site matters

    Head, body and tail tumours present differently — head lesions cause obstructive jaundice earliest.

  • Resectable disease

    A Whipple’s procedure is offered for resectable tumours of the pancreatic head.

  • Advanced disease

    FOLFIRINOX or gemcitabine + nab-paclitaxel are the standard systemic regimens.

Why this guide matters

Early diagnosis is hard — but the pathway is changing.

Modern imaging, EUS-guided biopsy and neoadjuvant chemotherapy have shifted what is possible — for resectable, borderline and advanced disease alike.

  • Painless jaundice is the classic prompt

    Yellow skin and eyes without pain, especially with weight loss, needs a 2-week-wait referral — every time.

  • Pancreas-protocol CT comes first

    A dedicated CT is the first-line imaging test — a routine abdominal scan can miss important detail.

  • MDT decides resectability

    A specialist hepatobiliary MDT — not any single scan — decides whether surgery is possible and in what order.

How the diagnosis is made

From first symptoms to a clear plan.

The pancreas-protocol imaging pathway UK hepatobiliary teams follow, in order — so you know what to expect and why.

  1. 01

    Assessing

    Symptom + risk history

    Jaundice, weight loss, new diabetes and family history are pieced together into an early clinical picture.

  2. 02

    Assessing

    LFTs — obstructive pattern

    Liver function tests showing an obstructive jaundice pattern raise the suspicion of a pancreatic head lesion.

  3. 03

    Assessing

    Abdominal CT (pancreas protocol)

    A dedicated pancreas-protocol CT scan is the first-line imaging test — it defines the lesion and vascular involvement.

  4. 04

    Confirming

    MRI / MRCP

    MRI with MRCP gives a detailed view of the pancreatic duct, biliary tree and any liver metastases.

  5. 05

    Confirming

    Endoscopic ultrasound + biopsy

    EUS-guided fine-needle biopsy gives a tissue diagnosis and staging information in one procedure.

  6. 06

    Planning

    CA 19-9 (prognostic, not screening)

    CA 19-9 is used to help judge prognosis and monitor treatment — it is not a screening test.

  7. 07

    Planning

    HPB MDT

    A specialist hepatobiliary multi-disciplinary team decides resectability and the treatment sequence.

Typical timeline: 2–4 weeks from suspected diagnosis to an HPB MDT treatment plan.

Symptoms

What pancreatic cancer actually shows up as.

Early pancreatic cancer is often silent. When symptoms do appear they can be subtle — here is what to watch for and when to act.

  • Painless obstructive jaundice

    Yellow skin and eyes, dark urine and pale stools — classically painless in a head-of-pancreas tumour.

  • Weight loss

    Unintentional, progressive weight loss is one of the commonest presenting symptoms.

  • Epigastric / back pain

    A dull upper-abdominal pain that radiates through to the back — often worse at night.

  • New-onset diabetes

    Diabetes appearing in an older adult without obvious risk factors deserves careful thought.

  • Steatorrhoea

    Pale, greasy, hard-to-flush stools point to pancreatic exocrine insufficiency.

  • Depression before diagnosis

    A new low mood — sometimes months before other symptoms — is a recognised early feature.

  • Migratory thrombophlebitis

    Recurrent superficial vein clots in different sites (Trousseau’s sign) can precede diagnosis.

  • Red flag

    Painless jaundice with weight loss — a 2-week-wait suspected cancer pathway referral.

Treatment

How pancreatic cancer is treated in the UK.

Treatment depends on stage, resectability and fitness — from Whipple’s surgery for resectable disease to systemic chemotherapy and specialist palliative care.

  • Whipple’s (pancreaticoduodenectomy)

    The standard curative operation for resectable tumours of the pancreatic head.

  • Distal pancreatectomy

    Removes the body and tail of the pancreas, often with the spleen — for left-sided tumours.

  • Total pancreatectomy

    Removes the whole pancreas — used selectively for extensive or multifocal disease.

  • Neoadjuvant FOLFIRINOX

    Chemotherapy given before surgery to shrink borderline-resectable tumours and improve outcomes.

  • Adjuvant modified FOLFIRINOX

    Chemotherapy after successful resection — the modern UK standard where fitness allows.

  • Gemcitabine + nab-paclitaxel

    A first-line regimen for advanced pancreatic cancer, particularly where FOLFIRINOX is not tolerated.

  • Palliative biliary stent

    An ERCP-placed stent relieves obstructive jaundice and improves quality of life.

  • Best supportive care

    Symptom control, pancreatic enzyme replacement and specialist palliative input at every stage.

What this guide is based on

The sources behind every number on this page.

UK and European guidance, specialist society standards and patient-organisation resources, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or hepatobiliary team knows your history and can tell you which parts apply to you.

  • National Institute for Health and Care Excellence (NICE). Pancreatic cancer in adults: diagnosis and management (NG85).

  • Pancreatic Cancer UK. Patient information and treatment resources.

  • European Society for Medical Oncology (ESMO). Clinical practice guidelines on pancreatic cancer.

  • Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS).

Red flags

When pancreatic cancer becomes an emergency.

Pancreatic cancer can escalate quickly. These are the situations where you should act today rather than wait for the next appointment.

  • Cholangitis

    Fever, jaundice and right-upper-quadrant pain — an emergency needing biliary drainage and antibiotics.

  • Massive GI bleed

    Haematemesis or melaena in known pancreatic cancer requires urgent endoscopy and resuscitation.

  • Palliative-stage crisis

    Uncontrolled pain, vomiting or breathlessness — contact the specialist palliative team today.

  • Post-Whipple leak / bleed

    Fever, tachycardia or drain changes after pancreaticoduodenectomy — immediate surgical review.

  • Neutropenic sepsis on FOLFIRINOX

    Fever within days of chemotherapy — call the acute oncology helpline and attend hospital.

  • Hepatic decompensation

    Confusion, ascites or worsening jaundice in liver-involved disease needs same-day assessment.

  • Pain crisis

    Sudden, severe upper abdominal or back pain — do not wait for the next clinic appointment.

  • Bowel obstruction

    Distension, vomiting and absolute constipation — attend A&E for urgent imaging.

  • Venous thromboembolism

    New leg swelling or breathlessness — pancreatic cancer strongly raises the risk of DVT and PE.

Living with it

Complex care, with structured support.

Four things that make the biggest difference day to day — nutrition, symptom control, specialist nurse contact and structured follow-up.

A quiet reminder

Ask about pancreatic enzymes early.

Pancreatic enzyme replacement (PERT), pain control and dietetic input all work best when they’re set up from the start of treatment.

  1. 01 Nutrition

    Pancreatic enzymes matter

    Enzyme replacement (PERT) is essential after resection and often in advanced disease — ask for it early.

  2. 02 Symptoms

    Pain and jaundice control

    Structured pain control, biliary stenting and antiemetics are part of standard care from diagnosis onwards.

  3. 03 Support

    Specialist nurse contact

    A clinical nurse specialist and the acute oncology helpline are your fastest route to advice out of clinic.

  4. 04 Follow-up

    Structured HPB follow-up

    Regular hepatobiliary follow-up with imaging and CA 19-9 keeps treatment on track and side-effects managed.

Frequently asked

Everything we get asked about pancreatic cancer.

Quick answers on CT, MRCP, EUS, Whipple’s surgery, FOLFIRINOX and when to worry.

  • What is pancreatic cancer?

    Pancreatic ductal adenocarcinoma (PDAC) is the most common form — a cancer arising from the duct cells of the pancreas. There are around 10,500 new cases each year in the UK.

  • Why is pancreatic cancer often diagnosed late?

    Early pancreatic cancer usually causes no symptoms, and when they do appear (weight loss, back pain, new diabetes) they are non-specific. Painless jaundice is the classic prompt for urgent referral — but many tumours are already advanced when found.

  • How is pancreatic cancer diagnosed?

    A dedicated pancreas-protocol CT scan is the first-line test, often followed by MRI/MRCP and an endoscopic ultrasound (EUS) with fine-needle biopsy to confirm the diagnosis and stage. CA 19-9 is used for prognosis and monitoring, not screening.

  • What is a Whipple’s procedure?

    A pancreaticoduodenectomy (Whipple’s) removes the head of the pancreas along with the duodenum, gallbladder and part of the bile duct. It is the standard curative operation for resectable tumours of the pancreatic head, performed in specialist hepatobiliary centres.

  • What is FOLFIRINOX?

    FOLFIRINOX is a combination chemotherapy regimen (5-FU, leucovorin, irinotecan and oxaliplatin) used as neoadjuvant, adjuvant and first-line treatment for pancreatic cancer in patients fit enough to tolerate it. Modified FOLFIRINOX is the current UK adjuvant standard where possible.

  • Is pancreatic cancer inherited?

    A small but important proportion of pancreatic cancers are linked to inherited mutations — including BRCA1/2, Lynch syndrome and hereditary pancreatitis. A strong family history should prompt genetics referral, and can change treatment options.

Related content

Keep reading.

WhatsApp Call us
Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

Confidential. We respond within one working day.